These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. MK-571, a potent antagonist of leukotriene D4-induced bronchoconstriction in the human. Kips JC, Joos GF, De Lepeleire I, Margolskee DJ, Buntinx A, Pauwels RA, Van der Straeten ME. Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):617-21. PubMed ID: 1892302 [Abstract] [Full Text] [Related]
3. Effect of RG 12525, an oral leukotriene D4 antagonist, on the airway response to inhaled leukotriene D4 in subjects with mild asthma. Wahedna I, Wisniewski AS, Tattersfield AE. Br J Clin Pharmacol; 1991 Oct; 32(4):512-5. PubMed ID: 1958449 [Abstract] [Full Text] [Related]
6. The bronchopulmonary pharmacology of SK&F 104353 in anesthetized guinea pigs: demonstration of potent and selective antagonism of responses to peptidoleukotrienes. Torphy TJ, Newton JF, Wasserman MA, Vickery-Clark L, Osborn RR, Bailey LS, Yodis LA, Underwood DC, Hay DW. J Pharmacol Exp Ther; 1989 May; 249(2):430-7. PubMed ID: 2542530 [Abstract] [Full Text] [Related]
7. Participation of the cysteinyl leukotrienes in the acute bronchoconstrictor response to inhaled platelet activating factor in man. Spencer DA, Evans JM, Green SE, Piper PJ, Costello JF. Thorax; 1991 Jun; 46(6):441-5. PubMed ID: 1858084 [Abstract] [Full Text] [Related]
18. Effect of verapamil and sodium cromoglycate on leukotriene D4 induced bronchoconstriction in patients with asthma. Roberts JA, Rodger IW, Thomson NC. Thorax; 1986 Oct; 41(10):753-8. PubMed ID: 3097863 [Abstract] [Full Text] [Related]
19. Prevention of exercise-induced bronchoconstriction by a new leukotriene antagonist (SK&F 104353). A double-blind study versus disodium cromoglycate and placebo. Robuschi M, Riva E, Fuccella LM, Vida E, Barnabe R, Rossi M, Gambaro G, Spagnotto S, Bianco S. Am Rev Respir Dis; 1992 Jun; 145(6):1285-8. PubMed ID: 1595992 [Abstract] [Full Text] [Related]